You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

B-cell malignancy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-cell Lymphoma, Non-Hodgkin Lymphoma, B-cell Malignancy Trial (CTX112)

Not yet recruiting
  • B-cell Lymphoma
  • +7 more
  • CTX112
  • (no location specified)
Dec 12, 2022

B-cell Malignancy, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (AS-1763)

Not yet recruiting
  • B-cell Malignancy
  • +7 more
  • (no location specified)
Oct 26, 2022

Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)

Not yet recruiting
  • Hematopoietic Stem Cell Transplantation
  • Hematologic Malignancy
  • CliniMACS®
  • (no location specified)
Oct 17, 2023

B-cell Malignancy Trial in Sanhe (CD19-CAR-T cells)

Completed
  • B-cell Malignancy
  • CD19-CAR-T cells
  • Sanhe, Hebei, China
    Hebei Yanda Ludaopei Hospital
Jan 28, 2022

B Cell Malignancy Trial in Sanhe (CD19-STAR-T cells)

Completed
  • B Cell Malignancy
  • CD19-STAR-T cells
  • Sanhe, Hebei, China
    Hebei Yanda Ludaopei Hospital
Jan 28, 2022

Relapsed/Refractory B-Cell Malignancies Trial in Australia, China (HSK29116)

Recruiting
  • Relapsed/Refractory B-Cell Malignancies
  • Perth, Australia
  • +7 more
Aug 1, 2022

Relapsed or Refractory B-cell Malignancy(NHL/ALL) Trial in Luoyang (ET-02)

Recruiting
  • Relapsed or Refractory B-cell Malignancy(NHL/ALL)
  • ET-02
  • Luoyang, Henan, China
    •The First Affiliated Hospital of Henan University of Science an
Aug 26, 2021

Relapsed/Refractory B-cell Malignancies Trial (AC676)

Not yet recruiting
  • Relapsed/Refractory B-cell Malignancies
  • (no location specified)
Mar 27, 2023

B-cell Malignancy, Low-grade, Non-Hodgkin Lymphoma, Mantle Cell Lymphoma Trial in China (BGB-16673)

Recruiting
  • B-cell Malignancy, Low-grade
  • +4 more
  • Beijing, Beijing, China
  • +8 more
Jul 20, 2022

Myeloid Malignancy, Acute Myeloid Leukemia Trial in Cleveland (Venetoclax, Decitabine)

Not yet recruiting
  • Myeloid Malignancy
  • Acute Myeloid Leukemia
  • Cleveland, Ohio
    University Hospitals Seidman Cancer, Case Comprehensive Cancer C
Nov 8, 2023

B Cell Malignancy Trial in Hefei, Suzhou (ThisCART19 cells)

Recruiting
  • B Cell Malignancy
  • ThisCART19 cells
  • Hefei, Anhui, China
  • +1 more
Dec 20, 2021

B-cell Malignancy Trial in Xuzhou (ThisCART22 cells)

Recruiting
  • B-cell Malignancy
  • ThisCART22 cells
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Nov 9, 2021

B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma Trial in Australia, United States (BGB-16673)

Recruiting
  • B-cell Malignancy
  • +8 more
  • Phoenix, Arizona
  • +14 more
Jan 17, 2023

B-cell Malignancy Trial in Xuzhou (ThisCART19 cells)

Recruiting
  • B-cell Malignancy
  • ThisCART19 cells
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Oct 25, 2021

Hematologic Malignancy, Large B-cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Los Angeles (autologous hematopoietic stem

Not yet recruiting
  • Hematologic Malignancy
  • +5 more
  • autologous hematopoietic stem cells added to planned CAR T
  • Los Angeles, California
    Cedars-Sinai Medical Center
May 31, 2023

Hematologic Malignancy Trial in Duarte (B. infantis (PBCLN-014) and Human Milk Oligosaccharides (HMO) (PBCLN-010))

Recruiting
  • Hematologic Malignancy
  • B. infantis (PBCLN-014) and Human Milk Oligosaccharides (HMO) (PBCLN-010)
  • Duarte, California
    City of Hope
Oct 20, 2023

CB-Long-Term Safety Study (CB-LTSS)

Enrolling by invitation
  • Lymphoma, Non-Hodgkin
  • +7 more
  • Allogeneic CAR-T therapy
  • Irvine, California
  • +3 more
Nov 18, 2022

Venetoclax Tablets Crushed and Dissolved Into a Solution

Not yet recruiting
  • Hematologic Malignancy
  • +18 more
  • 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid) of patients prescribed venetoclax as crushed tablets per standard of care.
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Nov 8, 2023

B-cell Leukemia, B-Cell Lymphoma Trial in Uppsala (CAR T cells)

Completed
  • B-cell Leukemia
  • B-Cell Lymphoma
  • CAR T cells
  • Uppsala, Sweden
    Uppsala University Hospital, Dept of Oncology
Oct 14, 2021

B-Cell Lymphoid Malignancies, Hematologic Malignancy, Non-Hodgkin Lymphoma Trial in Miami (Hematopoietic Stem Cells from

Recruiting
  • B-Cell Lymphoid Malignancies
  • +2 more
  • Hematopoietic Stem Cells from HLA-compatible Related
  • Hematopoietic Stem Cells from HLA Unrelated
  • Miami, Florida
    Miami Cancer Institute at Baptist Health of South Florida
May 5, 2022

Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in Milwaukee

Enrolling by invitation
  • Monoclonal Gammopathy of Undetermined Significance
  • +6 more
    • Milwaukee, Wisconsin
      Aurora Health Care
    Jul 20, 2021

    Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)

    Not yet recruiting
    • Hematologic Malignancy
    • +21 more
    • (no location specified)
    Feb 9, 2023

    B-cell Malignancy, Non-Hodgkin Lymphoma, B-cell Lymphoma Trial in Worldwide (CTX110)

    Recruiting
    • B-cell Malignancy
    • +3 more
    • CTX110
    • Los Angeles, California
    • +27 more
    May 6, 2022

    MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular

    Recruiting
    • Monoclonal Gammopathy of Undetermined Significance (MGUS)
    • +8 more
      • Boston, Massachusetts
      • +6 more
      Apr 14, 2022

      B-cell Lymphoma, Chronic Lymphocytic Leukaemia, Waldenström Macroglobulinemia Trial in United Kingdom (BI-1206 single agent dose

      Completed
      Has Results
      • B-cell Lymphoma
      • +2 more
      • BI-1206 single agent dose escalation phase
      • +3 more
      • Leicester, England, United Kingdom
      • +4 more
      Jun 17, 2021